CEO,, 10% Owner of Pain Therapeutics (PTIE, Financial) Remi Barbier sells 50,000 shares of PTIE on 11/05/2009 at an average price of $4.83 a share.
Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs such as morphine into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers. Pain Therapeutics has a market cap of $208.5 million; its shares were traded at around $4.94 with and P/S ratio of 3.3.
Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs such as morphine into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers. Pain Therapeutics has a market cap of $208.5 million; its shares were traded at around $4.94 with and P/S ratio of 3.3.
Insiders' Positions with PTIE
- Sell:: CEO, 10% Owner Remi Barbier sold 20,000 shares of PTIE stock on 10/02/2009 at the average price of 5.1, the price of the stock has decreased by 3.14% since
- Sell:: CEO, 10% Owner Remi Barbier sold 23,200 shares of PTIE stock on 09/11/2009 at the average price of 5.23, the price of the stock has decreased by 5.54% since
- Sell:: President and CEO, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 06/05/2009 at the average price of 5.26, the price of the stock has decreased by 6.08% since
- Sell:: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 26,800 shares of PTIE stock on 05/16/2009 at the average price of 5.23, the price of the stock has decreased by 5.54% since
Insiders' Positions with PTIE
- Sell:: CFO Peter S Roddy sold 40,000 shares of PTIE stock on 08/31/2009 at the average price of 5.08, the price of the stock has decreased by 2.76% since
Insiders' Positions with PTIE
- Sell:: 10% Owner Capital Management Eastbourne sold 3,076,915 shares of PTIE stock on 09/29/2009 at the average price of 4.98, the price of the stock has decreased by 0.8% since
- Sell:: 10% Owner Capital Management Eastbourne sold 1,663,000 shares of PTIE stock on 08/07/2009 at the average price of 3.96, the price of the stock has increased by 24.75% since
- Sell:: 10% Owner Capital Management Eastbourne sold 90,778 shares of PTIE stock on 07/14/2009 at the average price of 4.23, the price of the stock has increased by 16.78% since
- Sell:: 10% Owner Capital Management Eastbourne sold 368,000 shares of PTIE stock on 07/07/2009 at the average price of 4.58, the price of the stock has increased by 7.86% since
- Sell:: 10% Owner Capital Management Eastbourne sold 368,000 shares of PTIE stock on 07/07/2009 at the average price of 4.58, the price of the stock has increased by 7.86% since
